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Asthma from childhood to adulthood: course
and outcome of lung function
P. M. GUSTAFSSON AND B. KJELLMAN
Department of Paediatrics, Central Hospital, Sko¨vde, Sweden
Lung function (FEV1 before and after bronchodilatation) was studied prospectively over five visits in 55 asthmatic
children (28 boys) from childhood to adulthood (age 30). At the last follow-up recordings were made at rest, after
cold air challenge (CACh), and after bronchodilatation. Results were related to clinical asthma scoring and to
sensitization to furred animals, as described in a companion paper.
Lung function outcome was shown to be influenced by initial FEV1 (% predicted) and gender, but not by initial
asthma severity or sensitization. FEV1 (% predicted) was higher in females than in males over the first two follow-
ups, but the reverse was found over the subsequent visits. It deteriorated from childhood to adulthood in the
females but improved in the males. In adulthood the females (for height 170 cm) had a steeper normalized annual
fall in post-bronchodilator FEV1 than the males (55+38 vs. 25+36 ml; P=0006). The degree of bronchial hyper-
responsiveness was associated significantly with asthma severity and the extent of sensitization to furred animals,
but not with gender.
The results indicate a better lung function outcome for asthmatic boys than for girls, confirming trends seen in
clinical asthma severity. In adulthood the extent of sensitization to relevant perennial inhaled allergens significantly
influences airway responsiveness and asthma severity, but not lung function.
Key words: adulthood; asthma; bronchial; challenge; childhood; cold air; course; follow-up; long-term; lung
function; outcome; prospective; reactivity.
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Few reports on the course of asthma from childhood to
adulthood have included several interim follow-up visits or
wide aspects on the clinical development of asthma, as well
as evaluation of lung function. In a companion paper we
have described the course of clinical asthma severity,
clinical allergy and allergic sensitization, and living condi-
tions in a cohort of 55 subjects with asthma randomly
recruited from an outpatient clinic and followed-up
prospectively with five interim visits from a mean age of
9–30 years (1). We found that asthma improved on the
whole from childhood to adulthood, but that the asthma
severity scores were initially higher in the boys than in the
girls. Asthma severity scores decreased significantly among
the males from childhood to adulthood, while the scores
were similar at the first and last follow-up in the females,
due to a tendency to worsened asthma among the females
during adult life. During childhood, half of the subjects had
an allergy to pollens, two-thirds were allergic to furredReceived 13 July 1999 and accepted in revised form 25 November
1999
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0954-6111/00/050466+09 $35?00/0animals, and clinical allergy and sensitization to inhaled
allergens (judged by skin prick tests and RAST) generally
persisted into adulthood. Despite the gender dierence in
the course of asthma severity, males and females did not
dier in the extension, severity or course of clinical allergy
or sensitization, in domestic exposure to furred animals, or
in social adaptation.
The aim of the current paper was to describe the
development of lung function from childhood to adulthood
in this group of 55 asthmatic subjects and to assess
the impact of gender, initial lung function, asthma severity
and allergic sensitization on the course and outcome of
lung function and on bronchial hyperresponsiveness in
adult age.
Study population and methods
STUDY SUBJECTS
The study subjects constituted a group of 55 adults (28
males) with childhood asthma which has been described
previously in detail (1). The participants were selected
randomly from an outpatient paediatric unit in a central
hospital, with the intention to include an equal number of
boys and girls. They were prospectively followed-up five
times after the initial visit (designated I, mean age; 94 yrs.)# 2000 HARCOURT PUBLISHERS LTD
COURSE AND OUTCOME OF LUNG FUNCTION IN CHILDHOOD ASTHMA 467over 21 years at the mean ages of 115 (II), 136 (III), 172
(IV), 243 (V) and 300 years (VI). Initially 57 children
fulfilled the criteria of selection, but the parents of one girl
did not give initial consent for the study and one girl died in
an attack of asthma at the age of 16, between visits II and
III. All the remaining 55 patients attended all the follow-up
visits. Four subjects (two males) had used inhaled
corticosteroids the year before visit V, and seven (five
males) during the year before the last follow-up visit. The
study was approved by the Local Ethics Committee when
initiated, and informed consent was obtained from the parents
(during childhood) and from the patients when adults.
LUNG FUNCTION TESTS AT VISIT II–V
Lung function at visit II–V was estimated with a wedge
spirometer (Vitalograph; Vitalograph Ltd, U.K.) before
and after inhalation of a solution of salbutamol from a jet
nebulizer (Pari-Boy; PARI GmbH, Starnberg, Germany) at
a dose of 015mg/kg b.w., with a maximum dose of 75mg,
deposited in the nebulizer. All subjects were sitting during
spirometry, and the maximum FEV1 result from three
technically correct recordings with optimal co-operation
was noted. Lung function testing was performed only when
the subjects were free from clinical asthma symptoms and
respiratory infections. Inhaled short-acting bronchodilators
were withheld for at least 12 h, and long-acting or oral
bronchodilators and antihistamines were withheld for 24 h.
The resting and post-bronchodilator FEV1 results reported
are expressed at BTPS.
LUNG FUNCTION TESTS AND
BRONCHIAL CHALLENGE AT VISIT VI
The participants refrained from asthma medication prior to
lung function testing as follows: short-acting bronchodila-
tors, inhaled corticosteroids, or sodium cromoglycate for
6 h; oral or long-acting bronchodilators for 18 h; and anti-
histamines for 48 h. Dynamic and static lung volumes were
recorded in a constant volume body plethysmograph
(Jaeger Masterscreen1; Erich Jaeger AG, Wu¨rzburg,
Germany). At least three technically correct recordings
were made, and the maximum FEV1 and inspiratory VC,
and the resulting FEV1/VC % results, were noted. In
addition the RV/TLC ratio is reported as an index of
hyperinflation. Subjects with a resting FEV1 of 65%
predicted (n=53) went through an isocapnoic cold air
hyperventilation challenge (CACh) to assess their degree of
indirect bronchial hyper-responsiveness. The provocation
was carried out by 4min of isocapnoic hyperventilation of
cold (7158C) dry air at 75% of the predicted maximum
voluntary ventilation (mvv=356predicted FEV1). A
slightly modified respiratory heat exchange system (Jaeger
RHES1; Jaeger AG, Wu¨rzburg, Germany) was used.
Dynamic and static lung volumes were measured at 2, 5
and 10min after the provocation was completed, and the
maximum fall in FEV1 (% of baseline) was calculated. A
fall in FEV1 of 10% was regarded as pathological (2), a
fall of 20–39% was regarded as moderately pathological,and a fall in FEV1 of 40% or more was regarded as severe.
After CACh the participants inhaled a 5mg/ml solution of
salbutamol for 2min from a jet nebuliser (Maxin1; Clinova
Medical AB, Malmo¨, Sweden). Fifteen minutes after
inhalation of the bronchodilator, spirometry was per-
formed in the same way as for baseline recordings. All
lung function test results reported are expressed at BTPS.
REFERENCE VALUES FOR SPIROMETRY
All spirometric results were expressed as percentages from
Swedish reference values for children up to 18 years of age
(3), and from the age of 20 years reference values for
Swedish adult males (4) and females (5) were used. In the
interval between 18 and 20 years the predicted value was
calculated as the average of the extrapolated values from
the childhood and the adult reference materials.
SERUM IGE ANTIBODIES TO FURRED
ANIMALS DANDER
S-IgE antibodies were determined with Phadebas RAST
(Pharmacia Diagnostics; Uppsala, Sweden) using the
RAST class rating 0–4, where a positive RAST implies an
arbitrary concentration of 035 PRU ml71 and a RAST
class level of 2070 PRU ml71. Antibodies to dander from
cat, dog and horse were tested in all 55 subjects at visit III–
VI, and in 41 subjects at visit II. In the current paper RAST
class 2 or above to cat, dog or horse dander was regarded as
strongly significant for sensitization to perennial allergens
and were used for evaluation in relation to other
parameters. In the companion paper we discussed relevant
cut-o limits for a likely persistent sensitization (1).
ASTHMA SEVERITY SCORING
From visit II asthma severity was classified using a
symptom score (0–3) and a medication score (0–3), which
give a total asthma score of 0–6. This total score is based on
the events during the year preceding the follow-up. Further
details are given in the companion paper (1). A total asthma
score of 0–2 implies no or mild asthma, 3–4 moderately
severe asthma, and a score of 5–6 implies severe asthma.
DATA ANALYSIS AND STATISTICS
For group values the mean+1 SD is given. The annual fall
in FEV1 in adult age was assessed from the fall in FEV1
from visit V to visit VI (actual decline, ml yr71). In
addition, the individual dierence in FEV1 between the
two visits was normalized by dividing the annual fall by the
cube of standing height (ml HT73 yr71). The results were
expressed in actual annual decline for both sexes, as ml
HT73 yr71, and also as standardized (ml yr71) in a subject
with a height of 170m (6).
The unpaired Student’s t-test was used for parametric
comparisons between males and females, and the paired
t-test was used to assess the statistical significance of
FIG. 1. (a)Baseline FEV1 % predicted (mean and SD) for
males, females and both at visits II–VI. *P5005;
**P5001; ***P50*001 visit II vs. visits III–VI for
males, females, and both separately.
{{P5001 visit IV vs. visit VI, both.
#P5005; males vs. females.
§P5005 visit IV vs. VI, males. (b) Post-bronchodilator
FEV1 % predicted (mean and SD) for males, females and
both at visits II–VI. P5005; **P5001; ***P50*001
visit II vs. visits III–VI for males, females, and both
separately.
{{P5001 visit IV vs. visit VI, both.
#P5005; ##P5001; males vs. females.
§§P5001 visit IV vs. VI, males.
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within the whole group, or within subgroups. Dierences
between proportions were tested with the w2-test,
using Yate’s correction, or with the Fisher’s exact test if
an expected cell value was less than five (unpaired
comparisons), or with the McNemar’s test (paired compar-
isons). Multiple regression analysis was used to assess the
contribution of gender, initial lung function, and asthma
severity on adult lung function. A P-value below 005 was
regarded as statistically significant. Two-tailed tests were
used throughout.
Results
GENDER AND COURSE OF LUNG
FUNCTION
For the whole group the % predicted baseline FEV1 [Fig.
1(a)] increased slightly from the first follow-up session (visit
II; 938+126) to visit IV (978+140; P=0047), and then
declined from visit IV to visit VI (930+132; P=0002).
The post-bronchodilator % predicted FEV1 [Fig. 1(b)]
decreased significantly from visit II (1023+110) to visit VI
(978+115; P=0024), and decreased also significantly
from visit IV to visit VI (1042+116 vs. 978+115;
P=0002).
Among the females the % predicted baseline FEV1 [Fig.
1(a)] decreased significantly from visit II (976+127) to
visit VI (901+150; P=0018). The post-bronchodilator %
predicted FEV1 [Fig. 1(b)] decreased significantly from visit
II to visit IV (1067+117 vs. 1008+114; P=0033), to
visit V (992+112; P50001), and to visit VI (938+123;
P50001). Among the males the % predicted baseline
FEV1 [Fig. 1(a)] increased significantly from visit II
(903+117) to visit IV (1004+151; P50001), visit V
(994+136; P=0002), and visit VI (9581+106;
P=0004). A decrease of the % predicted baseline FEV1
was seen from visit IV to visit VI (P=0032). The post-
bronchodilator per cent predicted FEV1 [Fig. 1(b)] in-
creased significantly from visit II to visit IV (980+85 vs.
10764+111; P50001) and to visit V (1032+129;
P=0032), but only tended to increase to visit VI
(1018+92; P=0057). A decrease of the % predicted
baseline FEV1 was seen from visit IV to VI (P=0002).
The % predicted baseline FEV1 (Fig. 1A) was signifi-
cantly higher for the females than for the males at visits II
(P=0033) and III (P=0010), and was numerically lower
at visit IV to VI (not significant). The % predicted post-
bronchodilator FEV1 (Fig. 1B) was significantly higher for
the females than for the males at visits II (P=0003) and III
(P=0020), but significantly lower at visits IV (P=0028)
and VI (P=0010).
REVERSIBILITY
For the whole group the percentage increase of FEV1 after
bronchodilator therapy tended to decrease from visit II to
visit IV (100+116 vs. 74+95; P=0054) and decreasedsignificantly from visit II to visits V (41+42; P50001),
and VI (63+101; P=0015). No significant gender
dierence was seen in reversibility at any follow-up session.
INITIAL LUNG FUNCTION, GENDER AND
INITIAL ASTHMA SEVERITY VS. FURTHER
COURSE OF LUNG FUNCTION
Multiple regression analysis showed that both initial
baseline % predicted FEV1 and gender contributed to
baseline % predicted FEV1 at the last visit (R
2 adjusted
030; P50001). Female sex was associated with a less
favourable outcome of lung function. For sex, the
regression coecient (beta) was 037 (P=0003), and for
initial baseline % predicted FEV1 it was 056 (P50001).
The multiple regression analysis also showed that both the
initial post-bronchodilator % predicted FEV1 and sex
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dicted FEV1 at the last visit (R
2 adjusted=025; P50001).
The female sex was associated with a less favourable
outcome of post-bronchodilator lung function. For sex, the
regression coecient (beta) was 051 (P50001) and for
initial post-bronchodilator % predicted FEV1 it was 045
(P=0001). The regression analysis showed no significant
influence of initial asthma severity on baseline or post-
bronchodilator FEV1 outcome.
SENSITIZATION TO FURRED
ANIMALS AT VISIT III AND COURSE OF
LUNG FUNCTION
Among the 11 males who had RAST results class 2 or
above to three dander allergens (cat, dog and horse) at visit
III a significant increase in baseline % predicted FEV1 was
seen from visit III (844+157) to IV (985+180;
P50001), V (995+116; P50001) and VI (936+125;
P=0002). These males also showed a significant increase in
post-bronchodilator % predicted FEV1 from visit III to IV
(935+80 vs. 1076+125; P50001), and to V (1045+98;
P=0002). In the remaining 18 males lung function did not
consistently improve. Among the 18 females with 1–2 or 3
RAST results class 2 or above to the three dander allergens
at visit III, no significant changes in baseline % predicted
FEV1 were seen. In the group of nine females without
sensitization to the animal danders at visit III, significant
reductions in % predicted baseline FEV1 were seen from
visit III (981+126) to visit V (915+90; P=0047) and to
visit VI (841+155; P=0001). Among the 10 females with
RAST results class 2 or above to all three perennial
allergens at visit III, a significant decrease in post-
bronchodilator per cent predicted FEV1 was seen from
visit III to VI (1027+1185 vs. 921+107; P=0006). InTABLE 1. Annual decline in baseline and post-bro
between follow-up visit V and VI. Results are
annual decline divided by the cubic of the standin
standard subject. (The results are given after exclu
increase in baseline FEV1 [+161 l] and one fema
between the two visits.) Unpaired Student’s t-tes
Male
(n=27
FEV1 decline (ml yr
71) Mean (
Baseline 495 (45
Post-bronchodilator 320 (40
FEV1 decline (ml HT
73 yr71)
Baseline 84 (7
Post-bronchodilator 55 (7
FEV1 decline (ml yr
71)
in a 170 m subject
Baseline 387 (37
Post-bronchodilator 252 (35the eight females sensitized to one or two perennial, no
significant changes in post-bronchodilator FEV1 were seen,
and in the group of nine females without sensitization
significant reductions in % predicted FEV1 were seen from
visit III (1072+115) to visits V (961+76; P=0003), and
VI (895+97; P=0010).
DECLINE IN FEV1 BETWEEN VISITS
V AND VI
The annual decline in post-bronchodilator FEV1 normal-
ized for height diered significantly (P=0008) between the
sexes (Table 1). On average the fall in lung function in the
females was twice as rapid as in the males. All six current
tobacco smokers were females, and they had higher
symptom scores than the non-smoking women (1). The
annual decline in post-bronchodilator FEV1 among the six
smokers was 432+244ml compared to 498+361ml
among the non-smoking females (n.s.).
BRONCHIAL HYPERRESPONSIVENESS
TO CACH
Twenty-four (12 males) of 53 subjects tested showed
pathological bronchial hyperresponsiveness to CACh. In
two subjects who had severe asthma and were sensitized to
all three furred animals, the baseline FEV1 was too low to
allow a challenge. Eleven subjects (six females) had a
moderate or severe reaction after CACh.
vs. lung function
No significant dierences in bronchial hyperresponsiveness
to CACh were seen between groups of patients who had anchodilator FEV1 among males and females
given as actual average annual decline, as
g height (HT3) and as decline in a 170m tall
sion of two outliers: one male with a marked
le with a marked decline in FEV1 [7157 l]
t
s Females
) (n=26)
SD) Mean (SD) P-value
8) 440 (362) 0629
6) 495 (332) 0098
6) 102 (88) 0446
1) 113 (78) 0008
1) 500 (434) 0329
8) 553 (381) 0006
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or above 100 at visit II or at visit VI.
vs. asthma severity
Thirteen of the 53 subjects tested at visit VI had at that time
a moderately severe asthma (score 3–4), 38 had mild asthma
(score 0–2), and four severe asthma (score 5–6). The fall in
FEV1 after CACh was 253+153% in the subjects with
moderately severe asthma, and 117+120 in those with
mild asthma (P50038). Among the 13 subjects with
moderately severe asthma, three had a mild hyperrespon-
siveness and six had a moderate or severe response. In theTABLE 2. Number of subjects with pathological
challenge) at follow-up visit VI. (RSD=residua
TLC=total lung capacity)
Finding
Baseline FEV15pred. mean 7164 RSD
Baseline FEV1/VC %5pred. mean 7164 RSD
Baseline RV/TLC5pred. mean+164 RSD
10% increase in FEV1 after beta-2
Fall in FEV110% after CACh
Fall in FEV120% after CACh
Any abnormality
FIG. 2. Number of subjects among 53 tested who showed
fall in FEV1 of 510%; 10–19% or 20% after cold air
hyperventilation challenge (CACh) at visit VI in relation
to the number of positive RAST results (class 2–4) to
three furred animals (cat, dog, horse) at the same visit.
(Two subjects with RAST positive to all three allergens
and severe asthma were not tested due to too low baseline
lung function.) **P5001; proportions of subjects with a
fall FEV1 of 10% or more; the group of subjects with
three positive RAST vs. the two other groups.38 subjects with mild asthma, nine had a mild hyper-
responsiveness and five had a moderate or severe response.
The proportion of subjects with moderate or severe
reactions in the two groups diered significantly (6/13 vs.
5/38; P=0021; OR 566; 95% CI 110–3100).
vs. RAST
Eighteen male and female subjects without any RAST
results class 2 or above to cat, dog or horse dander showed
a maximum fall of FEV1 after CACh of 84+51%, which
was significantly lower than among the 14 subjects with
three RAST results class 2 or above (250+130%;
P50001). The dierence between those with 1–2
(123+147%) and those with three positive RAST results
class 2 or above was also significant (P=0002). In the
group without any RAST results class 2 or above to
cat, dog or horse dander, five of 18 subjects displayed
bronchial hyper-responsiveness (all mild) to CACh com-
pared to 12 of 14 subjects in the group with three RAST
results class 2 or above (P=0002; Fig. 2). The proportion
of subjects with bronchial hyper-responsiveness to CACh
was also significantly lower in the group with 1–2 (7/21)
than among those with three positive RAST class 2 or
above (P=0005; Fig. 2).
NUMBER OF SUBJECTS WITH ANY
ABNORMALITY AT VISIT VI
Pathological responsiveness to CACh (24/53 subjects)
was the most common finding (Table 2) and significantly
more frequent than the second most common abnormality
(reduced FEV1/VC %, nine/55 subjects; P=0002; OR
423, 95% CI 159–1148). Hyperinflation (RV/TLC4pre-
dicted mean+164 RSD) was seen only in four females.
Discussion
Overall, the 55 asthmatic subjects followed over a 21-year
period in this study had a good lung function (% predictedfindings at spirometry and CACh (Cold air
l standard deviation; RV=residual volume;
Males Females Both
(n=28) (n=27) (n=55)
4 3 7
5 4 9
0 4 4
5 2 7
12 12 24
5 6 11
16 13 29
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adolescence, after which there was some decline. The degree
of reversible obstruction decreased from childhood to
adulthood. During childhood, lung function was better
among the girls than the boys, but the reverse was seen in
adulthood. While lung function deteriorated from child-
hood to adulthood among the females, it improved among
the males. Males, but not females, with poor lung function
during childhood displayed improved values during adult-
hood, and there was a steeper annual decline in lung
function among the adult female subjects than among the
males as assessed from post-beta2 FEV1-recordings.
The extent of sensitization to furred animal danders, the
most relevant perennial allergens in this part of Sweden (7),
had little influence on the development of resting or post-
bronchodilatation lung function. The current extent of
sensitization to furred animals was, however, strongly
related to the degree of responsiveness to CACh in adult
age and also to asthma severity. No significant relationship
was seen between bronchial hyperresponsiveness in adult
age and gender, nor was there any significant relationship
between hyperresponsiveness in adult age and asthma
severity or lung function during childhood.
METHODOLOGICAL ASPECTS
Only one subject was lost during follow-up, a girl who died
in an asthma attack when she was 16 years old, but all
remaining 55 subjects attended all five follow-ups over a 21-
year period. By necessity, investigations such as this, which
assess the course of lung function during childhood,
adolescence and adulthood, suer from methodological
shortcomings. In growing subjects it is more dicult than in
adults to assess the influence of disease or other factors on
repeated lung function measures expressed in absolute
volumes. Other options include the use of a control group,
or to relate the results to predicted values from a suitable
reference population. As pointed out by Quanjer (8)
predicted values are derived from cross-sectional studies
and are not necessarily representative for findings in
longitudinal studies. Observations over time in the same
adult subjects have demonstrated less decline in FEV1 over
time than cross-sectional findings, and it has been proposed
that the decline in FEV1 is negligible during the second and
third decade, after which it gradually increases (9–11). An
observed decline in FEV1 during adulthood relatively
steeper than predicted by reference values obtained from
cross-sectional studies would thus be an underestimation
rather than an overestimation of the true decline.
Another problem is the change in reference material and
values from childhood to adulthood. Furthermore, the
Swedish reference values do not include the period between
age 18 and 20. We utilized the largest modern reference
material available for Swedish children and adolescents for
which data were collected during the 1970s (3), and for
adulthood we used material collected during the 1980s
(4,5). For the interval between 18 and 20 the predicted value
was averaged from the extrapolated values from the
paediatric and adult reference materials. Optimally acontrol group should have been included when the present
study was initiated, but this was not feasible. It is, however,
reasonable to believe that the shortcomings that these
methodological problems imply do not undermine conclu-
sions made from the observed dierences in lung function
development between boys and girls.
At the last follow-up visit in this study we not only used
more advanced lung function testing equipment, but the
post-bronchodilator recordings of lung function were
undertaken after a CACh. It cannot be excluded that the
lung function values recorded after salbutamol inhalation
might have been somewhat greater if not preceded by this
challenge. On the other hand, a significantly more
ecacious jet nebulizer was used in the later visit compared
to the earlier visits. A possible remaining eect from the
provocation on post-beta2 lung function would, however,
aect males and females similarly, as they did not dier in
terms of responsiveness to the challenge.
OUTCOME IN RELATION TO
CHILDHOOD ASTHMA SEVERITY AND
LUNG FUNCTION
Asthma severity during childhood had little influence on the
course and outcome of lung function, while multiple
regression analysis demonstrated that initial lung function
had a significant influence, confirming previous observa-
tions by Gerritsen et al. (12) and Godden et al. (13).
Surprisingly, current asthma severity and lung function
showed no significant relationship. Ulrik and Lange (14)
have pointed out that it was shown 30 years ago that lung
function impairment diers not much between subjects with
active and those with quiescent disease (15), suggesting that
it could reflect irreversible damage (16,17).
OUTCOME IN RELATION TO
SENSITIZATION TO FURRED ANIMALS
Sensitization during adolescence to the three most impor-
tant perennial inhaled allergens in this group (cat, dog and
horse dander) had no apparent unfavourable impact on the
course of lung function. While atopy is a well established
risk factor for becoming asthmatic, we could not demon-
strate a negative influence of sensitization to relevant
inhalant allergens on the course of lung function, confirm-
ing findings made by Roorda et al. (18). Our results also
confirm previous observations by Almind et al. (19), who
saw no dierence in the decline in lung function between
adult asthmatics with or without atopic allergy. However,
Ulrik et al. (20) reported a more rapid decline in lung
function in non-allergic adult asthmatics (the majority
being females) than in those with allergic asthma.
OUTCOME IN RELATION TO GENDER
The % predicted FEV1 declined in females from childhood
to adulthood, while it increased among the males, with a
transition period occurring during adolescence. This gender
influence on lung function outcome appeared to be
472 P. M. GUSTAFSSON AND B. KJELLMANindependent of initial lung function and asthma severity.
The influence of the ‘regression to the mean’ phenomenon
(21,22) should be considered as a possible explanation for
the gender dierence in the course of lung function, i.e. that
those with poor lung function would tend to improve, and
vice versa. In the present study, however, the post-
bronchodilator results showed that boys with a slightly
impaired or good lung function improved, while in girls
with poor lung function there was a trend to deteriorate,
and among girls with only slightly impaired lung function
there was a significant impairment.
A significantly steeper annual fall in post-beta2 FEV1 was
seen in adulthood in the females (55+38ml) compared to
the males (25+36ml; P=0006), when normalized for a
standing height of 170m. Peat and co-workers (6)
investigated the mean annual loss of FEV1 over an 18-year
period in normal and asthmatic adult subjects recruited
from a health survey. They reported no gender or age
dierence in FEV1 decline, but lung function deteriorated
significantly more rapidly in asthmatic than in healthy
subjects. The mean slope of individual regressions of FEV1
was for non-smoking asthmatic males 505ml and females
387ml, normalized for a standing height of 170m. For
normal males and females it was 355 and 295ml, and for
smoking asthmatic males and females it was 602 and
399ml, respectively.
Ulrik and Lange reported from a Danish longitudinal
epidemiologic study, including 10 952 subjects observed
with an interval of 5 years, that the 177 asthmatic men and
the 219 asthmatic women had an average excess annual loss
of FEV1 of 39 and 11ml, respectively (14). Obviously
gender-related factors contribute to lung function outcome
in a complicated and still unknown way in asthmatic
subjects.
With the Swedish adult reference equations used in the
present study, it is dicult to compare the annual FEV1
decline between asthmatic males and females with the
predicted decline, because the regression equations are
constructed dierently for males and females (4,5). The
male regression equation is curvilinear, while the female
one is linear. The predicted annual FEV1 decline is 258ml
for females all through adulthood (5). The summary
regression equations for adult males and females presented
by the Working Party for ‘Standardization of lung function
test’ within the European Community for Steel and Coal
(23) indicate that the annual loss of FEV1 is 29ml in males
and 25ml in females all through the age group. Compared
to the observations by Peat et al. (6) and to the regression
equations from reference value publications (5,23), the
females in the current material appeared to have an
accelerated average FEV1 decline between the two
last follow-ups, while this was not the case among the
males (23).
In an epidemiologic survey, Lebowitz et al. reported
factors aecting the growth of pulmonary function between
55 and 25 years of age over an average of 88 years
in 353 subjects with three to seven observations (24).
Respiratory symptoms and diagnosis had the most
significant impact on lung function growth, while active
smoking came next. Parental smoking aected outcomealso, in interaction with active smoking and respiratory
diseases. As demonstrated in the companion paper (1),
there were no gender dierences in past or current
environmental conditions in the present cohort. Clinical
allergy and sensitization tended sooner to be more frequent
in males than in females, and in the present study the
gender eect on lung function was independent of
sensitization to relevant allergens.
There is no evidence that current tobacco smoking is the
cause of the observed gender dierence in lung function
decline. Six subjects were current smokers at the last follow-
up and five at the previous follow-up, all being females, but
the annual FEV1 decline did not dier between smoking
and non-smoking females. Seven subjects (two females)
were taking inhaled corticosteroids at the last follow-up,
and four (two females) at the previous visit. This low
number of steroid users suggests that dierences in regular
use of anti-inflammatory medication cannot account for the
sex dierence in course of lung function.
In a large review containing 115 references, Grol,
Gerritsen and Postma (25) carefully addressed which
factors influence the outcome of childhood bronchial
asthma. They found that only 10 prospective studies used
objective measurements. The influence of gender on the
outcome of lung function was reported only in three of the
10 papers (12,13,26), in addition to a previous report on the
current material (27). Gerritsen et al. performed a follow-up
study on initially 119 asthmatic children (39 girls) aged 6–14
years after a mean period of 16 years, and with 85%
attendance rate (12). Current symptoms tended to be more
frequent among the females, but no gender dierence in
baseline % predicted FEV1 was found, and for the whole
group no decline in lung function was seen. A follow-up
study on initially 406 (133 girls) asthmatic children 8–12
years of age from an outpatient clinic was performed by
Roorda et al. (26) after a mean period of 15 years, with an
attendance rate of 70%. Mean % predicted baseline FEV1
increased significantly from 91+16 during childhood to
96+18 when adults. The current occurrence of asthma
symptoms and need for asthma medication were predicted
by female sex, but no gender dierences in the outcome of
lung function were reported. The outcome of childhood
asthma after 25 years was studied by Godden et al. in a
Scottish community survey including 121 asthmatic chil-
dren (9–15 years), with a follow-up rate of 80% (13). The
findings did not suggest a gender influence on clinical
symptoms or peak flow variability. Females had a higher %
predicted baseline FEV1 than males, but greater bronchial
reactivity to metacholine.
It may seem surprising that the present study demon-
strates that female gender has a strikingly negative influence
on the outcome of lung function. Such a finding has not
been reported previously, although gender appears to be a
modifying factor for lung function decline in adult
asthmatics (14). The present study, however, diers from
previous studies in several aspects. Firstly, the asthmatic
children were recruited on the basis of including a similar
number of girls and boys, in contrast to previous studies in
which there were relatively few girls. Secondly, as many as
five follow-up sessions were used, and all but one patient, a
COURSE AND OUTCOME OF LUNG FUNCTION IN CHILDHOOD ASTHMA 47316-year old girl who died from asthma, reported at all
follow-up visits. Thirdly, at all visits spirometry was
performed before and after inhalation of a beta2-agonist.
The most significant sex-related dierences in lung function
were seen after bronchodilatation all through the study,
and in the assessment of the annual FEV1 decline during
adulthood. Several other observations suggest that gender
is of great importance in asthma. While asthma is more
frequent among boys than girls during childhood, the
reverse is seen after adolescence (28). Several studies
indicate that the long-term outcome of asthma is worse in
girls than in boys (26,29). Bronchial reactivity to methacho-
line was greater in females than males when adults in the
childhood asthma follow-up study by Godden et al. (13).
Furthermore, adult female asthmatics are more severely
aected by the disease than male asthmatics are (30). Our
own finding that the course of lung function tends to be less
favourable in asthmatic girls than boys is in line with these
dierent observations.
BRONCHIAL HYPERRESPONSIVENESS
Hyperventilation of dry cold air (CACh), i.e. a non-
pharmacological provocative stimulus, was used in the
present study to assess bronchial hyperresponsiveness.
Hyperventilation results in a hyperosmolar stimulus to
superficial cells on the airway mucosa due to evaporation of
fluid from the surface lining, and is believed to be the
stimulus causing exercise-induced bronchoconstriction (31,
32). It is believed that such stimuli cause a degranulation of
mast cells and other cells on the airway mucosa, resulting in
a release of substances causing airway obstruction (33). In a
study on children with a history of asthma, Steinbrugger et
al. (34) demonstrated that current asthma was more closely
related to responsiveness to CACh than to histamine
inhalation. Consequently, CACh is a relevant method to
define subjects with current asthma and to demonstrate
indirectly the presence of inflammatory cells in the airways.
In the present study, we found that the 13 subjects with
moderately severe asthma at visit VI had on average a
significantly greater fall in FEV1 after CACh than those 38
with mild asthma. No significant relationship between
resting lung function and bronchial responsiveness was
seen. On the other hand, there was a striking association
between the extent of sensitization to furred animals and
bronchial responsiveness. Gender did not influence bron-
chial responsiveness to hyperventilation of dry cold air.
These observations indicate that the gender eect on lung
function is mediated via other mechanisms than allergic
inflammation. Godden et al. (13) reported that bronchial
reactivity as measured with the methacholine test was
greater among females than males in their follow-up study.
Because methacholine acts directly on the airway smooth
muscles, it can be presumed that increased reactivity to
methacholine reflects properties inherent to the airway wall,
consequently their observations support rather than contra-
dict our interpretations.NUMBER OF LUNG FUNCTION
ABNORMALITIES AT VISIT VI
The rather low sensitivity of single baseline spirometry
recordings in follow-up of asthma is obvious, and
spirometry alone is seemingly a poor indicator of ongoing
allergic inflammation in the airways. On the other hand,
repeated measurements of lung function, particularly after
beta2-treatment, may disclose patterns not seen when only
single or few observations are made.
Conclusions
Initial lung function and gender, but not asthma severity or
sensitization to perennial allergens, had a significant
influence on lung function development from childhood
to adulthood in this cohort. Sensitization to relevant
perennial inhaled allergens was an important determinant
for asthma severity and bronchial hyperresponsiveness in
adulthood.
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